$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
纳武单抗在中国上市的时间
2025-10-19 11:44:20
Check Details
肾癌患者使用纳武单抗治疗的效果
2025-10-19 11:44:20
Check Details
纳武单抗治疗效果
2025-10-19 11:44:20
Check Details
纳武单抗的用法和用量
2025-10-19 11:44:20
Check Details
纳武单抗治疗晚期肺癌效果如何?
2025-10-19 11:44:20
Check Details
纳武单抗对晚期肺癌能有多大效果?
2025-10-19 11:44:20
Check Details
纳武单抗医保后的价格
2025-10-19 11:44:20
Check Details
纳武单抗国内上市了吗?售价多少?
2025-10-19 11:44:20
Check Details
纳武单抗可以医保吗?
2025-10-19 11:44:20
Check Details
晚期肺腺癌:EGFR-TKIs联合二甲双胍可显著改善患者的PFS
2025-10-19 11:44:20
Check Details
Ensartinib(恩沙替尼)可使ALK阳性NSCLC无进展生存率提高一倍
2025-10-19 11:44:20
Check Details
TRK+肺癌人群中拉罗替尼治疗的缓解持久性研究
2025-10-19 11:44:20
Check Details
1
2
...
3584
3585
3586
3587
3588
3589
3590
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
3
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
4
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
5
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
6
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
7
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
8
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
9
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
10
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
11
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
12
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes